AUPH FY 2012 Earnings — Aurinia Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena

AUPHAurinia Pharmaceuticals Inc.

$2B

FY 2012 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$6M+563.9% YoY

Gross Profit

$6M99.2% margin

Operating Income

-$5M-88.8% margin

Net Income

-$10M-158.1% margin

EPS (Diluted)

$-2.74

Cash Flow

Operating Cash Flow

-$7M

Free Cash Flow

-$7M

Stock-Based Comp.

$276,429

Balance Sheet

Total Assets

$4M

Total Liabilities

$6M

Stockholders' Equity

-$2M

Cash & Equivalents

$184,956

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$6M	$927,522	+563.9%
Gross Profit	$6M	$742,410	+723.2%
Operating Income	-$5M	-$6M	+15.1%
Net Income	-$10M	-$2M	-304.5%